JW Shinyak, Exclusive Distributor of French Pierre Fabre's 'Hair Strengthening Cosmetics'... First in Asia

JW Shinyak announced on the 11th that it has signed an exclusive domestic sales contract with French company Pierre Fabre for the hair strengthening cosmetic 'Ducray Neoptide Expert.'

JW Pharmaceutical announced on the 11th that it has signed an exclusive domestic sales contract with France's Pierre Fabre for the hair strengthening cosmetic 'Ducray Neoptide Expert.' Yonggwan Kim, CEO of JW Pharmaceutical (right), and Hyunjin Jeon, CEO of Pierre Fabre Korea, are posing for a commemorative photo after signing the contract.
[Photo by JW Pharmaceutical]

JW Shinyak will be responsible for the domestic distribution and sales of Ducray Neoptide Expert based on its sales and marketing capabilities. Through this contract, Pierre Fabre plans to introduce Ducray Neoptide Expert to the Asian market for the first time. With this sales contract, JW Shinyak has expanded its presence from finasteride and dutasteride-based hair loss treatments to the hair strengthening cosmetics market.

French pharmaceutical company Pierre Fabre owns more than 10 brands including the dermocosmetic brand Av?ne, as well as Ducray, A-Derma, Ren? Furterer, and Klorane. Ducray’s total brand sales amount to approximately 200 million euros (about 280 billion KRW), with hair care products accounting for about 25% of that.

Ducray Neoptide Expert is a cosmetic product specifically developed for thin and weak hair through clinical trials. It contains effective hair strengthening ingredients such as Silybum marianum, known as milk thistle, and Lespedeza capitata. The product is designed to be sprayed onto the scalp, offering ease of use.

A JW Shinyak representative stated, "Through this contract with Pierre Fabre, a leading dermocosmetic company, we have expanded our dermocosmetic lineup to include hair strengthening cosmetics. We will provide various treatment options to patients troubled by thin and weak hair and further strengthen our position in the domestic hair care market."

Meanwhile, JW Shinyak holds oral hair loss treatments such as 'Monad Tablets' and 'Monasta Tablets,' which contain finasteride as the main ingredient, and 'Dutamoa Tablets,' which contain dutasteride. In March, JW Shinyak began domestic distribution and sales of the hair loss treatment topical agent 'El-Kranel Alpha Solution,' used for female hair loss treatment, through an exclusive sales contract with Galderma Korea.